News
A study by a Yale scientis suggests that dasatinib and similar drugs at low doses could be effective treatment for cardiovascular defects related to Noonan syndrome (NS), a genetic disorder that results in severe heart defects, and should be considered for clinical trials.
According to the American Heart Association, nearly one-fourth of those hospitalized with have been diagnosed with cardiovascular complications, which have been shown to contribute to roughly 40% of all COVID-19-related deaths.
When will we be able to stop social distancing, throw away our masks, and return to life as we know it? Read on to find out.
Dr. Rachael Lampert talks to WTNH about the cardiovascular concerns for college athletes affected by COVID-19.
Rachel Lampert, MD, FACC, was inducted into the Association of University Cardiologists and presented at their annual meeting on Thursday, January 14, 2021.
Researchers are soon expected to release initial findings from a national cardiac registry of NCAA athletes who have tested positive for COVID-19, giving hope to health care professionals trying to better understand the impact of the disease on the heart.
In registry data covering more than 40,000 patients with myocardial infarction followed for almost 4 years, those with the largest early reductions in LDL-C appeared to reap the greatest reductions in adverse cardiovascular events.
Helen Parise, ScD, joins Yale Cardiovascular Medicine with two decades of experience designing, implementing, and analyzing clinical research.
Publicly reported percutaneous coronary intervention (PCI) mortality data may be misleading with regard to cardiologists who perform PCI at multiple centers, new research suggests.
The MyROAD pre-recorded audio instruction card for at-home care and self-management improved 30-, 45- and 90-day clinical outcomes in patients following HF hospitalization.
A Western lifestyle may be to blame for high blood pressure according to a report published in JAMA Cardiology.
Get accurate measurements at home and on-the-go with these devices.
The FDA greenlighted a new heart transplant method for use in a clinical trial at Yale New Haven (Conn.) Hospital that would significantly expand the amount of eligible donor hearts.
Right now, cholesterol treatment is more about finding ways to combine current cholesterol drugs a little bit differently and target treatment based on the person themselves.
Alex Stephens, 17, is the recipient of the first successful pediatric heart transplant in Connecticut.
COVID-19 “is the driving force behind” excess deaths among young adults ages 25 to 44 in the U.S. between March and July this year.
Boston doctors are warning in new research and in an op-ed in the New York Times that young people are dying at ‘historic rates’ from COVID-19.
New research shows that July may have been the deadliest month for young adults in modern American history.
The American Heart Association’s annual New Haven Go Red for Women Event will take place on Thursday, February 11, 2021.
The pandemic revealed that research doesn’t have to be the lumbering creature it’s been and can be more agile and efficient.
